Federal Judge Sentences Defendants Who Perpetrated $10.9 Million Medicare Fraud HIV Infusion Scheme
WASHINGTON, Aug. 7 /PRNewswire-USNewswire/ -- Miami physician Keith Russell, 65, and physician's assistant Jorge Luis Pacheco, 50, were each sentenced to 97 months in prison, and physician's assistant Eda Marietta Milanes, 43, was sentenced to 63 months in prison, for their roles in frau...Scientists learn why even treated genital herpes sores boost the risk of HIV infection
New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2. Scientists have uncovered details of an immune-ce...Los Angeles County Launches Its Most Comprehensive Campaign Ever to Encourage HIV Testing
LOS ANGELES, July 23 /PRNewswire/ -- This week the Los Angeles County, Department of Public Health's Office of AIDS Programs and Policy is launching its most comprehensive community outreach campaign ever to encourage HIV testing. In Los Angeles County, one in four of those who have...Adult Circumcision Reduces Risk of HIV Transmission Without Reducing Sexual Pleasure
LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Two studies presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA) show that adult circumcision reduces the risk of contracting the human immunodeficiency virus (HIV) and the risk of coital injury -- without...Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
Results of NIH-sponsored Clinical Trial to be Presented at Retrovirus Conference LEXINGTON, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced today that a National Institutes of Health (NIH)-sponsored clinical study found that participating wome...Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts
WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- The following is being released by Center for Health & Gender Equity: WHAT: World AIDS Day Audio Media Conference WHEN: Tuesday, November 25, 2008 11:00 a.m. EST Call-in number: 1-800-949-8476 RSVP strongly ...Determine HIV 1/2 - Serum & Plasma (CE marked) (20 Tests)
Description: For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...Determine HIV 1/2 - Serum & Plasma (CE marked) (100 Tests)
Description: For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...Determine HIV 1/2 - Whole blood (includes chase buffer) (100 Tests)
Description: For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...Determine HIV 1/2 - Serum & Plasma (100 Tests)
Description: For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...Determine HIV 1/2 - Whole blood (includes chase buffer) (20 Tests)
Description: For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...Determine HIV 1/2 - Serum & Plasma (20 Tests)
Description: For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...In vitro antibody production enables HIV infection detection in window period -- key to safer blood
This release is available in Chinese . Researchers in Israel and Kenya have shown that the contribution of variable degrees of immune suppression, either due to existing chronic infections such as parasitemi...Penn-Wistar team gains insight into HIV vaccine failure
PHILADELPHIA (July 20, 2009) A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast doubt on the feasibility of HIV-1 vaccines....New lab test offers better prediction of HIV microbicide safety
July 9, 2009 (BRONX, NY) Scientists at Albert Einstein College of Medicine of Yeshiva University have devised a laboratory test for predicting whether microbicides against HIV are safe for human use. The researchers have also discovered why several supposedly "safe" microbicides made women more ...Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. In their report, appearing in the July 2009 print issue of the Journal of Leukocyte Biology ( http://www.jleukbio.or...MicroRNAs help control HIV life cycle
LA JOLLA, Calif., June 26, 2009 Scientists at Burnham Institute for Medical Research (Burnham) have discovered that specific microRNAs (non-coding RNAs that interfere with gene expression) reduce HIV replication and infectivity in human T-cells. In particular, miR29 plays a key role in controllin...NIH funds $9.5 million for research on HIV and the human innate immune system
CLEVELAND Studying how the mouth wards off diseases will have implications for understanding overall how people stay healthy. The Case Western Reserve University School of Dental Medicine will use a five-year, $9.5 million grant from the National Institutes of Health's National Institute for Dent...Abbott HIV Test Demonstrates Earlier Disease Detection
CHICAGO, July 22 /PRNewswire-FirstCall/ -- Research presented today at the American Association for Clinical Chemistry annual meeting shows that an assay developed by Abbott for simultaneous detection of both HIV antigens and antibodies reduced the detection window by zero to nine days i...ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine
HALIFAX, NS, May 26 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based, clinical stage company that develops DNA vaccines. This research will formulate FIT Biotech's GTU(R) MultiHIV DNA pl...GSK and Pfizer Innovative Agreement Creates Specialist HIV Company
LONDON, April 16 /PRNewswire-FirstCall/ -- Pharmaceutical companies GlaxoSmithKline and Pfizer today announced an "innovative agreement" to pool their HIV assets creating a new world-leading, specialist HIV company. The deal will see the drug giants combine their existing HIV product an...